164 related articles for article (PubMed ID: 7979291)
1. Pharmacokinetics and safety of weekly dapsone and dapsone plus pyrimethamine for prevention of pneumocystis pneumonia.
Falloon J; Lavelle J; Ogata-Arakaki D; Byrne A; Graziani A; Morgan A; Amantea MA; Ownby K; Polis M; Davey RT
Antimicrob Agents Chemother; 1994 Jul; 38(7):1580-7. PubMed ID: 7979291
[TBL] [Abstract][Full Text] [Related]
2. Intermittent trimethoprim-sulfamethoxazole compared with dapsone-pyrimethamine for the simultaneous primary prophylaxis of Pneumocystis pneumonia and toxoplasmosis in patients infected with HIV.
Podzamczer D; Salazar A; Jiménez J; Consiglio E; Santín M; Casanova A; Rufí G; Gudiol F
Ann Intern Med; 1995 May; 122(10):755-61. PubMed ID: 7717598
[TBL] [Abstract][Full Text] [Related]
3. Dapsone-pyrimethamine compared with aerosolized pentamidine as primary prophylaxis against Pneumocystis carinii pneumonia and toxoplasmosis in HIV infection. The PRIO Study Group.
Girard PM; Landman R; Gaudebout C; Olivares R; Saimot AG; Jelazko P; Gaudebout C; Certain A; Boué F; Bouvet E
N Engl J Med; 1993 May; 328(21):1514-20. PubMed ID: 8479488
[TBL] [Abstract][Full Text] [Related]
4. Once-weekly administration of dapsone/pyrimethamine vs. aerosolized pentamidine as combined prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus-infected patients.
Opravil M; Hirschel B; Lazzarin A; Heald A; Pechère M; Rüttimann S; Iten A; von Overbeck J; Oertle D; Praz G
Clin Infect Dis; 1995 Mar; 20(3):531-41. PubMed ID: 7756472
[TBL] [Abstract][Full Text] [Related]
5. Primary prophylaxis for Pneumocystis carinii pneumonia: a randomized trial comparing cotrimoxazole, aerosolized pentamidine and dapsone plus pyrimethamine.
Mallolas J; Zamora L; Gatell JM; Miró JM; Vernet E; Valls ME; Soriano E; SanMiguel JG
AIDS; 1993 Jan; 7(1):59-64. PubMed ID: 8442918
[TBL] [Abstract][Full Text] [Related]
6. Four different regimens for prevention of Pneumocystis carinii pneumonia and toxoplasma encephalitis in HIV-infected patients.
Tocchetti A; Tambini R; Allegro A; Longoni E; Rinaldi E
AIDS; 1994 Feb; 8(2):272-4. PubMed ID: 8043236
[No Abstract] [Full Text] [Related]
7. Thrice-weekly cotrimoxazole is better than weekly dapsone-pyrimethamine for the primary prevention of Pneumocystis carinii pneumonia in HIV-infected patients.
Podzamczer D; Santín M; Jimenez J; Casanova A; Bolao F; Gudiol GR
AIDS; 1993 Apr; 7(4):501-6. PubMed ID: 8507417
[TBL] [Abstract][Full Text] [Related]
8. Toxicity and efficacy of daily vs. weekly dapsone for prevention of Pneumocystis carinii pneumonia in children infected with human immunodeficiency virus. ACTG 179 Study Team. AIDS Clinical Trials Group.
McIntosh K; Cooper E; Xu J; Mirochnick M; Lindsey J; Jacobus D; Mofenson L; Yogev R; Spector SA; Sullivan JL; Sacks H; Kovacs A; Nachman S; Sleasman J; Bonagura V; McNamara J
Pediatr Infect Dis J; 1999 May; 18(5):432-9. PubMed ID: 10353516
[TBL] [Abstract][Full Text] [Related]
9. Systemic Pneumocystis carinii pneumonia prophylaxis with dapsone and pyrimethamine fails to protect against extrapulmonary pneumocystosis.
Carlin EM; Coker RJ; Goldin RD; Harris JR
Genitourin Med; 1993 Apr; 69(2):130-2. PubMed ID: 8509094
[TBL] [Abstract][Full Text] [Related]
10. Levels of dapsone and pyrimethamine in serum during once-weekly dosing for prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis.
Opravil M; Joos B; Lüthy R
Antimicrob Agents Chemother; 1994 May; 38(5):1197-9. PubMed ID: 8067765
[TBL] [Abstract][Full Text] [Related]
11. A controlled trial of dapsone versus pyrimethamine-sulfadoxine for primary prophylaxis of Pneumocystis carinii pneumonia and toxoplasmosis in patients with AIDS.
Payen MC; De Wit S; Sommereijns B; Clumeck N
Biomed Pharmacother; 1997; 51(10):439-45. PubMed ID: 9863502
[TBL] [Abstract][Full Text] [Related]
12. Twice-weekly maintenance therapy with sulfadiazine-pyrimethamine to prevent recurrent toxoplasmic encephalitis in patients with AIDS. Spanish Toxoplasmosis Study Group.
Podzamczer D; Miró JM; Bolao F; Gatell JM; Cosín J; Sirera G; Domingo P; Laguna F; Santamaría J; Verdejo J
Ann Intern Med; 1995 Aug; 123(3):175-80. PubMed ID: 7598298
[TBL] [Abstract][Full Text] [Related]
13. A randomized trial of three antipneumocystis agents in patients with advanced human immunodeficiency virus infection. NIAID AIDS Clinical Trials Group.
Bozzette SA; Finkelstein DM; Spector SA; Frame P; Powderly WG; He W; Phillips L; Craven D; van der Horst C; Feinberg J
N Engl J Med; 1995 Mar; 332(11):693-9. PubMed ID: 7854375
[TBL] [Abstract][Full Text] [Related]
14. Hepatic and pulmonary pneumocystosis during primary prophylaxis for Pneumocystis carinii pneumonia with dapsone/pyrimethamine.
Podzamczer D; Martos A; Ferrer I; Santin M; Gudiol F
Clin Infect Dis; 1993 Jan; 16(1):171. PubMed ID: 8448298
[No Abstract] [Full Text] [Related]
15. Twice-weekly dapsone-pyrimethamine for preventing PCP and cerebral toxoplasmosis.
Clotet B; Sirera G; Romeu J; Gimeno JM; Jou A; Condom MJ; Tor J; Foz M
AIDS; 1991 May; 5(5):601-2. PubMed ID: 1863415
[No Abstract] [Full Text] [Related]
16. Meta-analysis of prophylactic treatments against Pneumocystis carinii pneumonia and toxoplasma encephalitis in HIV-infected patients.
Bucher HC; Griffith L; Guyatt GH; Opravil M
J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Jun; 15(2):104-14. PubMed ID: 9241108
[TBL] [Abstract][Full Text] [Related]
17. Dapsone/pyrimethamine may prevent mycobacterial disease in immunosuppressed patients infected with the human immunodeficiency virus.
Opravil M; Pechère M; Lazzarin A; Heald A; Rüttimann S; Iten A; Furrer H; Oertle D; Praz G; Vuitton DA
Clin Infect Dis; 1995 Feb; 20(2):244-9. PubMed ID: 7742423
[TBL] [Abstract][Full Text] [Related]
18. Low-dose co-trimoxazole, aerosolised pentamidine, or dapsone plus pyrimethamine for prevention of Pneumocystis carinii pneumonia.
Mallolas J; Zamora L; Gatell JM; Miró JM; Soriano E
Lancet; 1991 May; 337(8750):1162-3. PubMed ID: 1674036
[No Abstract] [Full Text] [Related]
19. Randomized trial of dapsone and aerosolized pentamidine for the prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis.
Torres RA; Barr M; Thorn M; Gregory G; Kiely S; Chanin E; Carlo C; Martin M; Thornton J
Am J Med; 1993 Dec; 95(6):573-83. PubMed ID: 8018144
[TBL] [Abstract][Full Text] [Related]
20. Aerosolized pentamidine, cotrimoxazole and dapsone-pyrimethamine for primary prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis.
Antinori A; Murri R; Ammassari A; De Luca A; Linzalone A; Cingolani A; Damiano F; Maiuro G; Vecchiet J; Scoppettuolo G
AIDS; 1995 Dec; 9(12):1343-50. PubMed ID: 8605054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
